BOSS ZHIPIN-W (02076) spent approximately 3 million US dollars on repurchasing 464,800 shares on June 30th.
BOSS Direct Recruitment -W(02076) announced that on June 30, 2026, the company will spend approximately 3 million US dollars to repurchase 46,480 shares at a repurchase price of $6.4125 to $6.50 per share.
BOSS ZHIPIN-W (02076) announced on June 30th, 2026 that the company will repurchase approximately 300 million US dollars worth of 464,800 shares at a repurchase price of 6.4125 to 6.50 US dollars per share.
Related Articles
TRANSTHERA-B(02617): The Phase II clinical trial of TT-01488 combined with anti-CD20 monoclonal antibody regimen for the treatment of peripheral T-cell lymphoma in China has been approved and will be launched.
COSCO Shipping Holdings (01919): Wan Min, Zhang Feng, Tao Weidong, Zhu Tao, and Xu Feipan have been appointed as executive directors.
Shanghai Pharmaceuticals Holding (02607): Shanghai Pharmaceuticals Group increased its holdings in the company's H shares by a total of 74 million shares through Shanghai Pharmaceuticals International.
TRANSTHERA-B(02617): The Phase II clinical trial of TT-01488 combined with anti-CD20 monoclonal antibody regimen for the treatment of peripheral T-cell lymphoma in China has been approved and will be launched.
COSCO Shipping Holdings (01919): Wan Min, Zhang Feng, Tao Weidong, Zhu Tao, and Xu Feipan have been appointed as executive directors.
Shanghai Pharmaceuticals Holding (02607): Shanghai Pharmaceuticals Group increased its holdings in the company's H shares by a total of 74 million shares through Shanghai Pharmaceuticals International.
RECOMMEND
